T, S., N, T., K, K., H, U., M, O., S, Y., . . . Y, S. (2025). Supportive Evidence of Surrogate End Points Based on Treatment Effect of Corticosteroid in IgA Nephropathy. Kidney international reports, 11(2), 103588. https://doi.org/10.1016/j.ekir.2025.09.002
Chicago Style (17th ed.) CitationT, Sasaki, et al. "Supportive Evidence of Surrogate End Points Based on Treatment Effect of Corticosteroid in IgA Nephropathy." Kidney International Reports 11, no. 2 (2025): 103588. https://doi.org/10.1016/j.ekir.2025.09.002.
MLA (9th ed.) CitationT, Sasaki, et al. "Supportive Evidence of Surrogate End Points Based on Treatment Effect of Corticosteroid in IgA Nephropathy." Kidney International Reports, vol. 11, no. 2, 2025, p. 103588, https://doi.org/10.1016/j.ekir.2025.09.002.